NCT01076244

Brief Summary

This is a single-center study evaluating the outcomes of patients with painful lumbar spinal stenosis who were treated with the mild procedure (minimally invasive lumbar decompression. The patients will be followed for 6 months after the procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2010

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

February 24, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 26, 2010

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

April 2, 2013

Completed
Last Updated

April 2, 2013

Status Verified

February 1, 2013

Enrollment Period

1.9 years

First QC Date

February 24, 2010

Results QC Date

February 22, 2013

Last Update Submit

February 22, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain as Measured by Visual Analog Scale (VAS).

    A validated ten point scale was used where ten is the worst possible pain and zero represents complete lack of pain. The change from baseline to six months is presented below, where a positive value represents the baseline value minus the 6 month value.

    Baseline and six months

Secondary Outcomes (3)

  • Improvement in Functional Mobility

    baseline and month 6

  • Quality of Life as Measured by the Symptom Severity Scale of the Zurich Claudication Questionnaire (ZCQ).

    Baseline and month 6

  • Quality of Life as Measured by Physical Function Scale of the Zurich Claudication Questionnaire (ZCQ).

    Baseline and month 6

Study Arms (1)

Minimally invasive lumbar decompression

OTHER
Procedure: Minimally Invasive Lumbar Decompression

Interventions

This minimally invasive procedure is performed under fluoroscopic image guidance through a dorsal approach to the spine. The patient is given local anesthesia and a sedative but needs to be responsive to the surgeon's questions for neurological monitoring. Under image guidance, the mild tools are inserted and positioned on the posterior spinal lamina, to the left or right of the spinous process. The tools are used to cut and remove tissue and bone from the posterior side of the lumbar spine to create a space inside the spine that can help decompress some of the spinal nerves.

Minimally invasive lumbar decompression

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptomatic and lumbar spinal stenosis caused by dorsal element hypertrophy
  • Prior failure of conservative therapy and Oswestry Disability Index (ODI) \>20%
  • Radiologic evidence of lumbar spinal stenosis, ligamentum flavum hypertrophy (typically \>2.5mm),confirmed by pre-op MRI/CT report
  • Central canal cross sectional area clearly reduced per MRI/CT report
  • If present, anterior listhesis \< or = to 5.0mm (preferred) and deemed stable by the Investigator
  • Able to walk at least 10 feet unaided before being limited by pain
  • Available to complete 26 weeks of follow up
  • A signed Consent Form is obtained from the patient
  • Adults 18 years of age or older

You may not qualify if:

  • Prior surgery at the intended treatment level
  • Compound fracture with intraspinal retropulsion contributing to spinal stenosis
  • Disabling back or leg pain from causes other than lumbar spinal stenosis
  • Disc protrusion or osteophyte formation severe enough to confound study outcome
  • Facet hypertrophy severe enough to confound study outcome
  • Bleeding disorders and/or current use of anti-coagulants
  • Use of acetylsalicylic acid (ASA) and/or non-steroidal anti-inflammatory drug (NSAID) within 5 days of treatment
  • Epidural steroids with 3 weeks prior to procedure
  • Inability of patient to lie prone for any reason with anesthesia support
  • Metabolic wound healing pathologies that may be deemed by the Investigator to compromise the study outcomes
  • Dementia and/or inability to give informed consent
  • Pregnant and/or breastfeeding
  • On workman's Compensation or considering litigation associated with back pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Center for Pain Relief, Inc.

Charleston, West Virginia, 25301, United States

Location

The Center for Pain Relief, Inc

Charleston, West Virginia, 25301, United States

Location

MeSH Terms

Conditions

Spinal Stenosis

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Results Point of Contact

Title
Timothy Deer
Organization
Center for Pain Relief

Study Officials

  • Timothy R Deer, MD

    Center for Pain Relief, Inc

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2010

First Posted

February 26, 2010

Study Start

February 1, 2010

Primary Completion

January 1, 2012

Study Completion

January 1, 2012

Last Updated

April 2, 2013

Results First Posted

April 2, 2013

Record last verified: 2013-02

Locations